AnalyzeDirect Broekmans FJ, Hompes PG, Heitbrink MA, Netelenbos CC, Roos JC, Falke TM, Schoemaker J. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy. Am J Obstet Gynecol. November 1996;175(5):1208-1216.
Publication Date
November 1996
How Analyze was Used
“Volume calculations were carried out with the use of a software system for the display and analysis of three-dimensional images obtained by MRI (Analyze version 6.2).”
Keywords
Adult
Antineoplastic Agents, Hormonal/administration & dosage
Bone Density
Female
Follicle Stimulating Hormone/blood
Humans
Leiomyoma/drug therapy/metabolism/pathology
Luteinizing Hormone/blood
Triptorelin Pamoate/administration & dosage
Uterine Neoplasms/drug therapy/metabolism/pathology
Author Affiliation(s)
Division of Reproductive Endocrinology and Fertility, Vrije Universiteit, Amsterdam, The Netherlands.
ID# 3031
Tags: Adult, Bone Density, Female, Follicle Stimulating Hormone/blood, Hormonal Antineoplastic Agents/administration & dosage, Humans, Leiomyoma/drug therapy/metabolism/pathology, Luteinizing Hormone/blood, Triptorelin Pamoate/administration & dosage, Uterine Neoplasms/drug therapy/metabolism/pathology